 |
Skyhawk Therapeutics
Last updated: September 13, 2024
The team
USA | Funding: $181.2M (+)
Website: https://www.skyhawktx.com/
Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA splicing process.They are now developing drug candidates for cancer, neurological disease, and rare disease.
Website: https://www.skyhawktx.com/
Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA splicing process.They are now developing drug candidates for cancer, neurological disease, and rare disease.
